Edward J. Bilsky
Affiliations: | Biological Sciences | The University of Northern Colorado |
Google:
"Edward Bilsky"Mean distance: 12.82
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vekariya RH, Lei W, Ray A, et al. (2020) Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a Mu Opioid Receptor Agonist/Delta Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects. Journal of Medicinal Chemistry |
| Stevenson GW, Giuvelis D, Cormier J, et al. (2020) Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration. Psychopharmacology |
| Streicher JM, Bilsky EJ. (2017) Peripherally Acting µ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications. Journal of Pharmacy Practice. 897190017732263 |
| McLane VD, Bergquist I, Cormier J, et al. (2017) Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal. Life Sciences |
| Lei W, Mullen N, McCarthy S, et al. (2017) Heat shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK Mitogen Activated Protein Kinase (MAPK) mechanism in mouse brain. The Journal of Biological Chemistry |
| Zhang Y, Williams DA, Zaidi SA, et al. (2015) 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) modulating the mu opioid receptor in a biased fashion. Acs Chemical Neuroscience |
| Lefever M, Li Y, Anglin B, et al. (2015) Structural Requirements for CNS Active Opioid Glycopeptides. Journal of Medicinal Chemistry. 58: 5728-41 |
| Stevenson GW, Luginbuhl A, Dunbar C, et al. (2015) The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence. Pharmacology, Biochemistry, and Behavior. 132: 49-55 |
| Zhang Y, Braithwaite A, Yuan Y, et al. (2014) Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. European Journal of Pharmacology. 736: 124-30 |
| Li Y, St Louis L, Knapp BI, et al. (2014) Can amphipathic helices influence the CNS antinociceptive activity of glycopeptides related to β-endorphin? Journal of Medicinal Chemistry. 57: 2237-46 |